Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.
As incomes continue to rise in more than 100 countries throughout Africa, Asia and Latin America, so too will the demand for better healthcare, convenience products, electronics, and household staples.
Telemedicine and EMR Interoperability – Two Patient-Centered Tech Advances – Can Help Us Overcome Fragmentation in the Health Ecosystem, but Only if We Have the Will to Make Them Work
Joseph Mercola, Robert F. Kennedy Jnr,Ty and Charlene Bollinger, Sherri Tenpenny, Rizza Islam, Rashid Buttar, Erin Elizabeth, Sayer Ji and Kelly Brogan, Christiane Northrup, Ben Tapper, Kevin Jenkins, Clay Clark